Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Hikma PharmaceuticalsEvotecCanopy GrowthBausch Health CompaniesAphria
Price Information
Current PriceGBX 2,571€24.32C$24.21C$25.36C$5.81
52 Week RangeHoldBuyBuyN/ABuy
Beat the Market™ Rank
Overall Score1.
Analysis Score2.
Community Score2.
Dividend Score2.
Ownership Score0.
Earnings & Valuation Score1.
Analyst Ratings
Consensus RecommendationHoldBuyBuyN/ABuy
Consensus Price TargetGBX 2,378.33€30.50C$38.55C$28.00C$8.64
% Upside from Price Target-7.49% downside25.41% upside59.21% upside10.41% upside48.79% upside
Trade Information
Market Cap£6.24 billion$3.68 billionC$11.27 billionC$9.05 billionC$1.55 billion
Average Volume822,1381,360,0002,752,828797,8313,770,203
Sales & Book Value
Annual Revenue£2.21 billion$461.99 millionC$384.91 millionC$8.60 billionC$518.70 million
Price / Sales2.837.9623.181.043.00
CashflowGBX 196.17 per share€2.12 per shareC$6.56 per shareC$9.13 per shareC$1.92 per share
Price / Cash13.1111.473.692.783.02
Book ValueGBX 873.80 per share€3.24 per shareC$15.05 per shareC$3.02 per shareC$6.88 per share
Price / Book0.037.501.618.410.84
Net IncomeN/AN/AN/AN/AN/A
EPSGBX 200€0.27C($6.11)C($5.36)C$0.12
Trailing P/E Ratio12.8690.07N/AN/A50.09
Forward P/E Ratio
P/E GrowthN/AN/AC($0.35)C$0.56N/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Annual PayoutGBX 48N/AN/AN/AN/A
Dividend Yield1.87%N/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout Ratio24.00%N/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity Ratio32.18%93.86%12.07%2,305.28%26.02%
Current Ratio1.26%2.51%7.59%1.12%5.19%
Quick Ratio0.82%2.30%5.71%0.81%3.37%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Shares Outstanding242.54 million151.24 million368.53 million353.36 million267.59 million
Next Earnings Date8/7/2020 (Estimated)8/12/2020 (Estimated)N/A8/4/2020 (Estimated)7/30/2020 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.